Source: Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Samantha J. Thulborn, Jennifer L. Cane, Clare Connolly, Catherine Borg, Kelly L. Moffitt, David Ribeiro, Charlene Robb, Richard E.K. Russell, Mona Bafadhel. Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD. Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019

Member's Comments

No comment yet.

Related content which might interest you: An improved assay for detection of sputum periostin in patients with asthma Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Evaluation of novel sputum processing methods and sensitive detection techniques in allergic asthmatics Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009 Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 The sensitivity and specificity of diagnostic methods in baker’s asthma Source: Eur Respir J 2004; 24: Suppl. 48, 368s Year: 2004 The sensitivity and specificity of specific IgE in diagnosing asthma Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 Sputum induction in asthmatic children: safety in children and feasibility of new methods of monitoring inflammation in sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006 Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Accuracy of the multidisciplinary diagnosis of COVID-19 in patients with negative nasopharyngeal swabs RT-PCR, evaluated using BAL as diagnostic gold standard. Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy Year: 2021 A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018 Year: 2019 The impact of different reference standards when estimating the accuracy of tests for diagnosing asthma Source: International Congress 2018 – Primary care management of asthma Year: 2018 Active detection of COPD, methods and results Source: Annual Congress 2009 - PG6 Core Curriculum Postgraduate Course: How to reduce the burden of COPD Year: 2009 Cross shift measurements of lung function have poor sensitivity and specificity in the diagnosis of occupational asthma Source: Eur Respir J 2006; 28: Suppl. 50, 244s Year: 2006 Development of a novel immunoassay for the measurement of active plasmin in patients with IPF Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Compatibility of a novel filter paper-based bio-safe sputum transport kit with line probe assay for diagnosing drug-resistant tuberculosis: a single-site evaluation study Source: ERJ Open Res, 7 (3) 00137-2021; 10.1183/23120541.00137-2021 Year: 2021 LSC - 2019 - Validating immunoproteasome activity as a potential biomarker in non-invasive samples from COPD patients Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Simultaneous analysis of sputum and serum biomarkers in adult asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Early detection of lung cancer in patients with COPD by eNose technology Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Comparison between the diagnostic yield of tissue Xpert MTB/Rif assay and culture in pleural tuberculosis patients. Source: International Congress 2019 – Interventional pulmonology: a mixture of spices Year: 2019